K-115 clinical pharmacology study

Clinical pharmacology study of K-115 in healthy volunteers

Status

Unknown

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080221879

Enrollment

Registered

2012-08-08

Start date

2012-08-08

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy volunteers

Interventions

investigational material(s) Generic name etc : K-115 INN of investigational material : Therapeutic category code : 131 Agents for ophthalmic use Dosage and Administration for Investigational material

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: 1. healthy Japanese male

Exclusion criteria

Exclusion criteria: 1.Patients whose refractive error is below -8 diopter. 2.Patients who had undergone ocular surgery 3.Patients thought to wear contact lenses during this trial etc.

Design outcomes

Primary

Measure	Time frame
Efficacy :MBR Safety :Adverse event (AE) and adverse drug reaction (ADR) Efficacy :Change from baseline in MBR Safety :Incidence of AE and ADR	—

Secondary

Measure	Time frame
Efficacy :IOP, etc Safety :Ophthalmologic examination, etc Efficacy : Change from baseline in IOP Safety :Change from baseline in ophthalmologic examination, etc	—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026